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Abstract 
Background: Extreme constitution “Prakriti” types of Ayurveda exhibit systemic physiological attributes. Our ear-
lier genetic study has revealed differences in EGLN1, key modulator of hypoxia axis between Prakriti types. This was 
associated with differences in high altitude adaptation and susceptibility to high altitude pulmonary edema (HAPE). 
In this study we investigate other molecular differences that contribute to systemic attributes of Prakriti that would be 
relevant in predictive marker discovery.
Methods: Genotyping of 96 individuals of the earlier cohort was carried out in a panel of 2,800 common genic SNPs 
represented in Indian Genomic Variation Consortium (IGVC) panel from 24 diverse populations. Frequency distribu-
tion patterns of Prakriti differentiating variations (FDR correction P < 0.05) was studied in IGVC and 55 global popula-
tions (HGDP–CEPH) panels. Genotypic interactions between VWF, identified from the present analysis, and EGLN1 was 
analyzed using multinomial logistic regression in Prakriti and Indian populations from contrasting altitudes. Spearman’s 
Rank correlation was used to study this genotypic interaction with respect to altitude in HGDP–CEPH panel. Validation of 
functional link between EGLN1 and VWF was carried out in a mouse model using chemical inhibition and siRNA studies.
Result: Significant differences in allele frequencies were observed in seven genes (SPTA1, VWF, OLR1, UCP2, OR6K3, 
LEPR, and OR10Z1) after FDR correction (P < 0.05). A non synonymous variation (C/T, rs1063856) associated with 
thrombosis/bleeding susceptibility respectively, differed significantly between Kapha (C-allele) and Pitta (T-allele) con-
stitution types. A combination of derived EGLN1 allele (HAPE associated) and ancestral VWF allele (thrombosis associ-
ated) was significantly high in Kapha group compared to Pitta (p < 10–5). The combination of risk-associated Kapha 
alleles was nearly absent in natives of high altitude. Inhibition of EGLN1 using (DHB) and an EGLN1 specific siRNA in 
a mouse model lead to a marked increase in vWF levels as well as pro-thrombotic phenotype viz. reduced bleeding 
time and enhanced platelet count and activation.
Conclusion: We demonstrate for the first time a genetic link between EGLN1 and VWF in a constitution specific 
manner which could modulate thrombosis/bleeding susceptibility and outcomes of hypoxia. Integration of Prakriti in 
population stratification may help assemble common variations in key physiological axes that confers differences in 
disease occurrence and patho-phenotypic outcomes.
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Background
There has been a deluge of variations from complete 
human genome sequencing projects [1, 2]. Majority of 
the common variations are shared across world popula-
tions and contribute to 98% inter-individual variance 
within populations [3–6]. Identification of meaningful 
variations that connect to human phenotypes and explain 
inter-individual variability in adaptation and susceptibil-
ity differences is the current challenge [7–10]. Integrative 
analysis of global variation data with environmental, geo-
graphical, dietary and cultural practices across diverse 
populations have helped identify common variations 
linked to local adaptations in different eco-clines like 
latitude, climate as well as mode of subsistence [11–16]. 
These variations correlate with phenotypic, physiologi-
cal and metabolic traits and overlap with signals from 
GWAS studies [8, 14–17]. Besides, system biology and 
data intensive approaches like PheWAS are being evolved 
to identify phenotypic links through shared genotypes 
[18–21]. There is a need to evolve methods to stratify 
individuals even within a genetically homogeneous popu-
lation on the basis of their shared physiological attributes 
that could give rise to different health trajectories.
India has a 3,500 year old system of medicine, Ayurveda 
which has at its basic tenet a predictive and participatory 
approach for preventive and personalized medicine [10, 
22]. In this approach healthy individuals are phenotypi-
cally stratified into seven different constitution types called 
Prakriti which also determines an individual’s differential 
susceptibility to disease, response to diet, environment 
and therapy [10, 22]. A unique aspect of this approach 
is that different phenotypic attributes of an individual, 
such as morphological features, skin type, physiology, 
metabolism, mental aptitudes, sensory perception etc. 
are comprehensively assessed for defining each constitu-
tion type [22]. Inter-individual variability in underlying 
physiological parameters related to different body tissues 
(qualitative and quantitative) have also been described. 
For instance, blood characteristics including color and 
viscosity are described to vary among different Prakriti as 
well as in response to geo-climatic conditions including 
seasonal variations. This also sets a prelude for differen-
tial susceptibility to blood related disorders like bleeding, 
hyper-coagulability or thrombosis. This forms the basis for 
personalized health maintenance and preventive medicine 
through diet and life style modifications (Additional file 1).
Amongst the seven types, Vata  (V), Pitta  (P) and 
Kapha  (K) are the three phenotypic extremes that are 
readily distinguishable [22–25]. Many of the phenotypic 
features that distinguish the predominant Prakriti types 
overlap with attributes described for human adapta-
tions. We have earlier provided molecular and genomic 
evidence of differences between contrasting constitution 
types from a genetically homogeneous background 
[22]. Common variations from a subset of differentially 
expressed genes also partitioned differently between the 
phenotypically stratified Prakriti groups [26]. Once these 
groups were pooled, the variations assumed an aver-
age frequency similar to the genetic background of the 
population. Further analysis of EGLN1 variation helped 
identify, hypoxia as one of the axis and capture genetic 
marker attributable to specific constitutions for high alti-
tude hypoxic adaptation [26].
We hypothesize that integration of the comprehensive 
phenotyping method of Ayurveda with genomics might 
provide scaffolds to connect major axes of variation to 
an individual’s phenome. In this study we carried out our 
analysis on a set of ~2,800 polymorphic genic SNPs, rep-
resented in the Indian Genome Variation Consortium 
panel [27, 28]. We identify common variations that dif-
fer between healthy individuals of contrasting Prakriti 
types in genes that govern blood cell traits, hemostasis, 
metabolism, lipid homeostasis, etc. We could thread 
hypoxia (EGLN1) to hemostasis (VWF) and red blood 
cell traits (SPTA1) in a constitution specific manner. 
We provide genetic and experimental evidence of how 
in the background of earlier reported EGLN1 variations 
that link to differences in hypoxia responsiveness, vWF 
variations/levels could modulate risk for thrombosis. 
We thus propose that an Ayurgenomics approach could 
enable assembly of common variations linked to differ-
ent physiological axes which could assume importance in 
adaptability to different geo-climatic conditions and sus-
ceptibility to diseases.
Methods
Study subjects
The study was carried out on the same samples [22, 26] 
that have been used in our earlier studies. Sample collec-
tion was carried out following approval of Institutional 
Bioethics Committee (IBC). Briefly the samples com-
prised of (1) 96 individuals comprising of extreme con-
stitution types Vata (n = 39) Pitta (n = 29) and Kapha 
(n = 28) identified from an initial phenotyping of 850 vol-
unteers on the basis of Ayurveda methods and recruited 
in our earlier study. (2) 552 samples from 24 diverse 
Indian populations from the existing panel of IGVC [26, 
28]. These include 92 heterogeneous phenotype controls 
(IE-pool) from Indo-European North Indian large popu-
lations (size >10 million).
Genetic study and analysis
We carried out our analysis on a panel of 2,800 SNPs from 
776 genes on whom the genotype information was avail-
able from the IGVC panel Phase II (http://igvbrowser.igib.
res.in, [29]). These SNPs were genotyped in VPK samples 
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using Illumina Bead Array platform. The SNPs tagged a set 
of representative genes/genic regions that have been impli-
cated in a number of monogenic and complex diseases. 
These genes mapped to diverse biological processes and 
molecular functions. Genotype data on EGLN1 and VWF 
from 55 populations were retrieved from the data of Stan-
ford Human Genome Diversity Panel (HGDP) SNP Geno-
typing Data on 650 K Illumina arrays available on HGDP 
selection browser (http://hgdp.uchicago.edu/, [30]). The 
altitude of each of the populations in the HGDP panel was 
retrieved from the earlier study [31].
Fisher’s exact test [32] was carried out for testing geno-
typic and allelic associations between the Prakriti types 
as well as between Prakriti and IE-pool background. 
Correction for multiple testing was done using the FDR 
method.
We compared the frequency of combined genotypes 
of EGLN1 and VWF between the Prakriti types and in 
high altitude natives and a related population from sea 
level (Additional files 2, 3). Combined genetic analy-
sis was carried out considering EGLN1 allele associated 
with high altitude adaptation and VWF allele associated 
with non thrombotic phenotype as protective alleles. We 
evolved a scoring mechanism wherein the total count of 
the protective alleles in EGLN1 and the VWF genotypes 
in an individual was calculated. Thus, a score of “0” cor-
responds to individuals homozygosity for the risk allele 
‘C’ at both rs480902/rs1063856 (that is, the genotype CC/
CC) and a score of 4 where all the alleles were protective 
(that is, the genotype TT/TT). All the nine genotypes 
were considered and converted to these scores. Multino-
mial logistic regression was performed to associate these 
scores and the Prakriti types (K/V/P). We used binary 
logistic regression to test for differences in the distribu-
tion of scores between (1) individuals residing at high 
altitude and those residing at sea-level and (2) individu-
als residing at high altitudes and the Prakriti group “P”. 
In order to study the possible relationship between the 
scores of individuals belonging to the different HGDP 
populations and the altitudes corresponding to these 
populations, we computed the Spearman’s rank correla-
tion between the mean scores of each population and the 
altitudes (Additional file 4).
Animals and experimental protocol
Male BALB/c mice (8–10  week old  with an average 
weight of 25 grams; obtained from CSIR-Central Drug 
Research Institute, Lucknow, India) were acclimatized for 
1 week before starting the experiments. All animals were 
maintained as per the guidelines of the Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), and the protocols were approved by 
the Institutional Animal Ethics Committee of CSIR-IGIB.
Ethyl‑3, 4‑dihydroxy benzoic acid (DHB) treatment
Mice were divided into three groups (n = 5–6), accord-
ing to the treatment: Vehicle (10% ethanol), D5 (DHB 
5 mg/kg), D10 (DHB 10 mg/kg). DHB (TCI AMERICA, 
Portland, OR, USA) and 10% ethanol was administered 
via Intraperitoneal (I.P.) injection at 100 µl volume for 7 
consecutive days.
siRNA treatment
Mice were divided into three groups (n = 5–6), according 
to the treatment: Naive (untreated mice), Scram siRNA 
(scrambled siRNA treated mice) and PHD2 siRNA 
(PHD2 siRNA treated mice). For assessing the systemic 
effect we used the intranasal route for siRNA delivery as 
described previously [31]. Briefly, 90 µg of PHD2 (Dhar-
macon, Lafayette, CO) or scrambled siRNA (Dharmacon, 
Lafayette, CO) dissolved in 30 ml of ultrapure DNase and 
RNAse free water was administered intranasally to isoflu-
rane-anesthetized mice. SiRNA was given on day 1, 3 and 
5. The animals were sacrificed on day 6 from the start of 
the experiment.
Tail bleeding assay (bleeding time assay)
On the final day of protocol (DHB or siRNA experiment), 
mice were anaesthetized in prone position. A 10 mm seg-
ment of the tail from the distal end was amputated with 
sharp scalpel. The tail was then immediately immersed 
in 50  ml of PBS (pre-warmed to 37°C in a water bath) 
contained in a Falcon tube. The position of tail was kept 
vertical with tip positioned about 2  cm below the PBS 
meniscus. The bleeding time was then determined by 
monitoring the duration of animal tail bleeding until it 
ceased, using a stop clock.
Biochemical analysis
Blood was obtained by cardiac puncture and collected 
in EDTA coated MiniCollect tubes (Greiner Bio-One 
Gmbh, kremsmünster, Austria). Plasma was isolated by 
centrifugation of blood at 1,000g for 15  min at 4°C and 
kept in −80°C for further use. HIF1α and vWF levels were 
measured in plasma sample by using ELISA kit (USCNk, 
Wuhan, China) as per the manufacturer’s protocol. The 
whole blood was used to measure the total count of 
platelets and its distribution width by using automated 
hematology analyzer (Nihon kohden, Japan). Assessment 
of active and total Platelet count was carried out through 
flow cytometry using FACSCalibur (BD Biosciences, 
USA). Briefly, 100  μl of blood was diluted in 400 μl of 
TBS. This diluted whole blood (1:4) was then incubated 
with APC conjugated anti-CD62P (eBioscience Inc, San 
Diego, CA, USA) and FITC conjugated anti-CD41 (eBio-
science Inc, San Diego, CA, USA) for 15  min. Matched 
fluorescein conjugated isotype control antibodies were 
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used simultaneously for staining, to set the threshold 
and exclude nonspecific binding. Activity was compared 
using CellQuest Pro software (BD Biosciences, USA).
Statistical analysis
Statistical significance was determined by the Student’s t 
test. Non parametric statistical test Mann–Whitney rank 
sum test or Wilcoxon matched pair test was used wher-
ever the data does not follow the Gaussian distribution. 
Analysis was done using GraphPad Prism software 5.0.
Results
Common variations partition differently amongst healthy 
individuals of extreme constitution types
Indian Genome Variation Consortium (Phase II) houses 
variation information on 2,800 tag SNPs from approxi-
mately 776 genic regions in diverse populations of India. 
We studied the distribution of these SNPs in Vata (V), 
Pitta (P) and Kapha (K) subgroups that were identified 
from our earlier study [22]. The details of recruitment 
and assessment of Prakriti types has been described ear-
lier [22]. 92 individuals who were not phenotyped for their 
constitution types but were from the same ethno-genetic 
background namely, Indo-European, large populations 
were used as heterogeneous phenotype controls (IE-pool).
The details of the populations are provided in methods 
above. We observed that nine SNPs from seven genes 
(SPTA1, VWF, OLR1, UCP2, OR6K3, LEPR, and OR10Z1) 
have significant allele frequency differences between the 
constitution types even after correction for multiple testing 
with false discovery rate threshold set at 5% (Figure  1; 
Table 1). Even though we had selected tag SNPs, two SNPs 
(rs857691, rs857721) of SPTA1 were different between P 
and K. P seemed to be differentiated from both V and K at 
the OLR1 locus (rs3741860). There was a significant differ-
ence between K and V at the OR6K3 (rs857703) and UCP2 
(rs660339) locus. P and K besides SPTA1 and OLR1 also 
differed at the VWF (rs1063856) and OR10Z1 (rs857685) 
locus. Most importantly, once the constitution types were 
pooled, these contrasting allele frequencies were averaged 
out and the pooled frequencies did not differ significantly 
from the IE-background. Further comparison of each 
constitution group with the IE-pool revealed significant 
difference (FDR correction at 5%) between P and IE with 
respect to LEPR (rs1171271), SPTA1 (rs857691, rs857721), 
OR10Z1 (rs857685) and V and IE with respect to OR6K3 
(rs857703) (Additional file 5).
Additive effect of VWF in high altitude adaptation 
with EGLN1
The frequency of the ancestral ‘C’ allele of rs1063856 in 
VWF gene, that is reported to be associated with athero-
sclerosis [33] was high in Kapha (Figure 1) whereas the 
derived allele was high in Pitta Prakriti. Incidentally, the 
allele linked to Pitta was nearly fixed in a native popu-
lation of Tibeto- Burman background residing at high 
altitude. In contrast in the Indo-European population, 
which was the background of these constitution types, 
the ancestral allele was more frequent (Figure 2). In the 
HGDP-CEPH population there was a clinal distribution 
Figure 1 Representation of allele frequencies of common variations amongst extreme constitution types. A representative set of SNPs that show 
significant difference between the constitution types Kapha (K), Pitta (P), Vata (V) and differ from the VPK/IE pool are depicted. The gene and SNP 
with the alleles are given in each panel. IE represents individuals with heterogeneous phenotypes from Indo-European populations and VPK repre-
sents individuals of different constitution types pooled into a single group.
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of the ancestral ‘C’ allele (rs1063856) of VWF with 
increase in frequency of derived non-thrombotic allele in 
the Eastern populations (Figure 2). 
Interestingly we reported a similar observation with 
respect to a genetic variation in EGLN1 linked to its 
expression in our earlier study. We observed a variation 
linked to lower expression of EGLN1 in Pitta Prakriti as 
well as natives of high altitude both in Indian and global 
populations whereas the other allele significantly overrep-
resented in Kapha and sea level sojourners who developed 
high altitude pulmonary edema [26]. However in case of 
EGLN1 it was ancestral allele that was fixed in natives of 
high altitude whereas in case of VWF we observed the 
derived allele linked to low levels of vWF to be nearly fixed 
in high landers. We hypothesize that low levels of EGLN1 
due to environmental hypoxia or a genetic variation could 
result in elevated vWF as a consequence of angiogenesis 
and confer thrombosis risk. Hence we anticipate, fixation 
of a non-thrombotic/derived allele in the background of 
protective EGLN1 genotype could give an advantage in 
high altitude condition as well as in conditions where HIF 
related pathways are expected to be elevated.
In order to test the above hypothesis, we compared the 
frequency of combined genotypes of EGLN1 and VWF 
between the Prakriti types and also compared their pres-
ence in high altitude natives and a related population 
from sea level as described in the methods above. Pitta 
differed significantly from Kapha (p value  7.4  ×  10−5) 
and Vata (p value  0.013) with respect to the additive 
score of the protective genotypes. This difference was 
also observed between the high altitude natives and 
their genetic counterpart from the lowland regions (p 
value 7.18 × 10−5). Both Pitta and high altitude natives 
had the genotype in EGLN1 that was HA associated and 
VWF that was linked to protection from thrombosis. 
This implies a physiological link between the hypoxia and 
hemostasis axes through genetic interactions between 
EGLN1 and VWF. The mean score of the protective gen-
otype also demonstrated a significant correlation with 
altitude (p value 0.009) in the HGDP–CEPH populations. 
This correlation was more strong in East Asian popula-
tions from the HGDP panel. Incidentally the high altitude 
population from India also belongs to the same genetic 
background (Figure 3).
Validation of a functional link between EGLN1 
and VWF in mouse model
We carried out a chemical inhibition study in mouse model 
to validate whether hypoxia condition confers an elevated 
risk for thrombosis through the EGLN1 axes. PHD (EGLN) 
inhibition was induced by Ethyl-3-4-dihydroxybenzoic acid 
(DHB) a general PHD inhibitor, in male BALB/c mice in 
two different doses. DHB was administered from day 1 to 
7 and animals were sacrificed on day 8 and bleeding time 
assay was performed. Other blood parameters were also 
measured on the same day. A dose dependent decrease in 
mouse tail bleeding time was observed after PHD2 inhibi-
tion. Treatment with DHB also significantly increased the 
total platelet count and its distribution width. Further, high 
dose of DHB increases the plasma VWF antigen levels (Fig-
ure 4). In order to address the question whether chemical 
inhibition of PHD was specific we tested the effect by spe-
cific siRNA treatment against PHD2 in mice. We observed 
PHD2 siRNA treatment to mice leads to significant 
decrease in tail bleeding time (Figure 5). In addition, siRNA 
knockdown of PHD2 lead to an increase in total platelet 
count drastically in mice blood. It also increased HIF-1α 
levels in plasma sample of mice (Figure  5). To confirm 
whether this observed effect is due to vWF, we checked the 
levels of vWF in plasma. We found that the PHD2 siRNA 
treatment causes an increase in vWF levels, which is border 
line significant (p < 0.0530) (Figure 5).
Table 1 SNPs that show significant differences between the Prakriti groups after FDR correction for multiple testing set 
at a threshold of significance of p < 0.05
Gene SNP Variation Comparison Allele Allele frequency 1 Allele frequency 2 P value
Allele frequency (1 vs. 2)
EPR rs1171271 C/T PvsK C 0.46 0.13 5.40E−05
OR6K3 rs857703 A/G KvsV A 0.11 0.43 4.44E−05
UCP2 rs660339 A/G KvsV A 0.15 0.49 4.23E−05
OLR1 rs3741860 A/G VvsP G 0.49 0.14 2.87E−05
OLR1 rs3741860 A/G PvsK G 0.14 0.53 6.35E−06
SPTA1 rs857691 C/T PvsK T 0.40 0.06 1.63E−05
SPTA1 rs857721 A/T PvsK A 0.43 0.05 6.05E−07
VWF rs1063856 C/T PvsK C 0.05 0.37 1.55E−05
OR10Z1 rs857685 A/C PvsK C 0.41 0.05 1.46E−06
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Figure 2 Distribution of ancestral ‘C’ allele (rs1063856) frequency of VWF gene associated with thrombosis in diverse IGVC and HGDP-CEPH popula-
tions. a Frequency in the 24 IGV populations. TB-N-IP1, a population from high altitude has fixation for the derived allele. b Spatial frequency map of 
rs1063856 in the HGDP-CEPH panel of 55 populations retrieved from HGDP selection browser. There is a clinal variation in the frequency of derived 
allele as populations moved out of Africa.
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Figure 3 Distribution of frequency of homozygous genotype scores (4) for protective alleles at both loci EGLN1. rs480902 and VWF rs1063856 in 
diverse HGDP-CEPH populations from different altitudes. Diverse populations especially from East Asia residing at high altitude selectively retain the 
combination of ancestral allele of EGLN1 and derived allele of VWF.
Figure 4 Effect of chemical inhibition of PHD or EGLN in mouse on various blood parameters. a Schematic representation of DHB experiment 
protocol. PHD inhibition was done by giving DHB (ethyl-3, 4, dihydroxybenzoic acid) treatment in mice. DHB was administered from day 1 to 7. 
On day 8 mice tail bleeding assay was performed. b Decrease in tail bleeding time of mice treated with DHB in a dose dependent manner. c, d 
PHD inhibition in mice by chemical DHB treatment leads to increase in total platelet count and its distribution width (considered here as active 
platelet parameter). Both parameters were assessed through automatic hematology analyzer in mouse whole blood (anticoagulated) as described 
in methods. e, f ELISA for estimation of HIF-1α and VWF antigen levels in mouse plasma after PHD inhibition. ND not detectable. Data shown as 
mean ± SEM. *p ≤ 0.05, ***p ≤ 0.001 (n = 6 per group).
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Discussion
We studied the distribution of common variations, rep-
resented in the IGVC panel, in the healthy individuals of 
extreme Ayurvedic constitution types. These predomi-
nant constitutions types belong to one of the genetically 
homogeneous clusters identified in the IGVC project 
that comprises Indo-European population from North 
India [27, 28]. We observed significant differences in 
SNP allele frequency in seven genes (SPTA1, VWF, 
OLR1, UCP2, OR6K3, LEPR, and OR10Z1) between the 
constitution types. These genes are important players in 
governing major axes like blood cell traits, hemostasis, 
metabolism and lipid homeostasis in healthy individu-
als and have also been associated with risk for bleeding 
disorders, CVD, stroke, obesity, atherosclerosis [34–42]. 
These not only differ between constitution types but also 
correlate with phenotypes that differentiate the Prakriti 
types. Prakriti as mentioned above not only exhibit 
phenotypic differences but also renders differential 
responsiveness to environmental conditions as well as 
susceptibility to diseases. Extreme Prakriti types in any 
population are at the end of phenotypic spectrum and 
have contrasting responsiveness to intrinsic and extrin-
sic stimuli. Majority of the variations that differ between 
Figure 5 Knockdown of PHD2 by siRNA in mice leads to pro-thrombotic phenotype. a Schematic representation of siRNA experiment protocol. 
Scrambled or PHD2 siRNA was given intra-nasally to mice on day 1, 3 and 5. On day 6 mice were subjected to tail bleeding assay. b Tail bleeding 
time (in seconds) measured in mice treated with siRNA (Scrambled or PHD2) or in untreated (naïve) mice groups as described in methods. c, d Total 
and active platelet count assessed in mouse whole blood via flow cytometry. CD62P and CD-41 antibody were used to label total and active plate-
lets respectively e, f ELISA for estimation of VWF and HIF-1α antigen levels in mouse plasma. Data shown as mean ± SEM. *p ≤ 0.05, ***p ≤ 0.001 
(n = 5–6 per group).
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the extreme Prakriti types are shared across diverse 
populations and their frequencies can vary on account 
of selection pressures such as climatic conditions, mode 
of subsistence, pathogen pressure and cultural practices 
even in genetically related populations [12–14], (Addi-
tional file 6). Many of these also overlap with signals 
associated with different diseases and phenotypic traits 
in GWAS studies [35–42]. Thus the same variation asso-
ciated with a constitution type could assume importance 
in adaptation or disease susceptibility/protection based 
on the context.
The ancestral ‘C’ allele of VWF rs1063856 has been 
associated with elevated plasma von Willebrand factor 
levels and the risk of incident venous thrombosis [43, 
44]. Besides mutation in VWF gene leading to its reduced 
expression has also been linked to bleeding susceptibility 
[33].
In an earlier study, we have reported expression and 
allelic frequency differences in an oxygen sensor EGLN1 
between Pitta and Kapha Prakriti types [26]. The geno-
type linked to higher expression of EGLN1 was observed 
in Kapha and HAPE. EGLN1 inactivates HIF-1a in high 
oxygen conditions. Under hypoxic conditions EGLN1 is 
inactive leading to elevated HIF-1a levels, which switches 
on a large number of genes including those linked to 
angiogenesis [45, 46]. The same variation in EGLN1 gene 
has been associated with high altitude adaptation in mul-
tiple populations of the world [47–49]. Levels of vWF 
have been shown to be elevated in cellular hypoxic condi-
tions [50–53].
It is conceivable that in the background of an ances-
tral favourable allele, there might be selection for 
newer alleles that are physiologically advantageous. For 
instance, in the presence of an ancestral allele of EGLN1 
that favours high altitude adaptation, elevated risk for 
thrombosis can arise as a consequence of angiogenesis 
due to high levels of vWF. We could functionally validate 
the observed link obtained between EGLN1 and VWF 
genotypes through chemical and siRNA mediated inhibi-
tion of PHD2 in a mouse model (Figures 4, 5). In the pres-
ence of hypoxia as a consequence of PHD2 inhibition not 
only VWF but markers that are associated with increased 
risk for thrombosis were observed to be elevated. Our 
results support the previous findings [54–56]. Thus 
increasing concentration of the chemical inhibitor DHB 
which inhibits the activity of PHD2 leading to enhanced 
hypoxic response results in a prothrombotic phenotype 
viz increased platelet count and activation and reduced 
bleeding time. This is in line with previous work showing 
that hypoxia elevates the VWF expression [50–53]. Thus, 
both chemical and siRNA mediated inhibition of PHD2 
leads to a pro-thrombotic phenotype in mice corroborat-
ing with our genetic finding.
Therefore, presence of a derived (non-thrombotic) 
allele of VWF in the background of elevated HIF could 
confer protection from thrombosis in Pitta Prakriti types 
as well as in high altitude natives.
The ancestral allele linked to higher level of VWF 
needed for coagulation might be important in protection 
from blood loss due to various reasons. However, this 
might not be favourable in high altitude where already 
a constitutive state of hypoxia can promote thrombosis. 
This could be the reason for near fixation of the derived 
non-thrombotic state of VWF in high altitude popula-
tion of India as well as in the other high altitude regions 
of the world. Incidentally the high altitude region in 
India where TB-N-IP1 resides is also classified as a dry 
desert. Prolonged low oxygen conditions and dryness 
are known to precipitate deep vein thrombosis through 
platelet aggregation for instance in long distance fliers. 
Our observation might also assume importance in iden-
tifying individuals who might be differentially susceptible 
to deep vein thrombosis.
In Ayurveda, seven different constitutions types 
with varying proportions of Vata, Pitta and Kapha are 
described to be present in all populations. These propor-
tions are determined by ethnicity, heritability, geo-cli-
matic adaptation, time and season which also govern the 
relative phenotypic optimum of the population. Prakriti 
assessment is carried out keeping these aspects in context 
for an individual. Prakriti integrates underlying physi-
ological variability, adaptation to different climatic condi-
tions as well as susceptibility to diseases. An environment 
such as high altitude which is described as Kapha-Vata 
promoting can lead to elevated Pitta component as a part 
of adaptation. However, amongst the sojourners from 
sea level who are not naturally adapted, individuals who 
have elevated Pitta levels might be more protected from 
high altitude sickness. This might explain the sharing of 
genotypes between high altitude natives and Pitta where 
adaptation might be a cause in the earlier one and in the 
later it can confer adaptability to high altitude environ-
ment. This observation lends credence to the Ayurveda’s 
personalized recommendation of diet and life style based 
on an individual’s constitution, habitat, seasons etc.
Conclusion
In this study, we demonstrate how stratification of nor-
mal healthy individuals can help uncover a novel and 
non-intuitive genetic link between hypoxia and hemo-
stasis axes that is important both in adaptation and dis-
ease susceptibility. Complementation of Ayurveda based 
phenotypic classification of healthy individuals with 
population, environmental and geographical genomics 
approaches might not only allow us to partition com-
mon variations among healthy individuals but also help 
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connect key physiological axes that confers differences 
in disease occurrence and patho-phenotypic outcomes. 
Given that Prakriti assessment is important in personal-
ized recommendations for health and disease manage-
ment, this could be important for translational medicine.
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